Tag: Pembrolizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Pembrolizumab

BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? - Yahoo Finance

Added to Collection on: 2025-09-13 11:31:47

Tags for this article:

Cancer immunotherapy
Lung cancer
Immune system
Clusters of differentiation
Orphan drugs
Checkpoint inhibitor
Pembrolizumab
PD-1 and PD-L1 inhibitors
Small-cell carcinoma
Vascular endothelial growth factor
Programmed cell death protein 1
PD-L1
BioNTech
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
BMY-BioNTech Partnership: A Potential Catalyst for Long-Term Gains? - sharewise

Added to Collection on: 2025-09-13 04:58:16

Tags for this article:

Cancer immunotherapy
Immune system
Lung cancer
Orphan drugs
Pfizer
Pembrolizumab
Checkpoint inhibitor
Bristol-Myers Squibb
PD-1 and PD-L1 inhibitors
BioNTech
Merck & Co.
Programmed cell death protein 1
Bristol-Myers Squibb Company
Bristol Myers

Click the tags to see associated articles and topics

View Article Details
The Guardian view on Merck's exit: Britain's biopharma strategy stalls in the face of China's rise

Added to Collection on: 2025-09-15 19:15:56

Tags for this article:

Pharmacy
Cancer immunotherapy
Medical research
Immune system
Ivonescimab
Pembrolizumab
AstraZeneca
Pharmaceutical industry
Programmed cell death protein 1
GSK plc
Pfizer
Medication costs
Merck
United States
United Kingdom

Click the tags to see associated articles and topics

View Article Details
PDS Biotech reports 29.5 months of mOS in low PD-L1 expression patients with head and ...

Added to Collection on: 2025-09-18 13:07:08

Tags for this article:

Cancer immunotherapy
Antineoplastic drugs
Pembrolizumab
Otorhinolaryngology
Infectious causes of cancer
Head and neck cancer
Human papillomavirus infection
TIGIT
Checkpoint inhibitor

Click the tags to see associated articles and topics

View Article Details
PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended ...

Added to Collection on: 2025-09-18 12:55:46

Tags for this article:

Cancer immunotherapy
Infectious causes of cancer
Virotherapy
Otorhinolaryngology
Pembrolizumab
Checkpoint inhibitor
Merck & Co.
Human papillomavirus infection
Forward-looking statement
Head and neck cancer
Immunotherapy

Click the tags to see associated articles and topics

View Article Details
IRR Rates May Be Lower Than Expected in the Real World - Hematology Advisor

Added to Collection on: 2025-09-18 13:48:19

Tags for this article:

Orphan drugs
Antineoplastic drugs
Nivolumab
Pembrolizumab
Atezolizumab
Ipilimumab
Monoclonal antibody
Pertuzumab
IRR
Durvalumab

Click the tags to see associated articles and topics

View Article Details
Five Under 5: Top Oncology Videos for the Week of 9/21 | OncLive

Added to Collection on: 2025-09-28 22:10:28

Tags for this article:

Orphan drugs
Antineoplastic drugs
Cancer immunotherapy
Pembrolizumab
Cancer treatments
Multiple myeloma
Daratumumab
Teclistamab
Chemotherapy

Click the tags to see associated articles and topics

View Article Details
Peaks and valleys in bispecific antibody research - BioXconomy

Added to Collection on: 2025-10-01 15:56:19

Tags for this article:

Immune system
Immunology
Antineoplastic drugs
Cancer immunotherapy
Orphan drugs
Pembrolizumab
Monoclonal antibody therapy
Checkpoint inhibitor
Nivolumab
Ipilimumab
Antibody-drug conjugate
Monoclonal antibody

Click the tags to see associated articles and topics

View Article Details
Cartography secures $67M in pursuit of 'differentiated' cancer drugs - BioPharma Dive

Added to Collection on: 2025-10-02 17:37:33

Tags for this article:

Antineoplastic drugs
Cancer immunotherapy
Immune system
Cancer treatments
Checkpoint inhibitor
Monoclonal antibody therapy
Pembrolizumab
Colorectal cancer
Cancer
Immunocore
Chemotherapy
Amgen

Click the tags to see associated articles and topics

View Article Details
Five Under 5: Top Oncology Videos for the Week of 10/5 | OncLive

Added to Collection on: 2025-10-12 14:18:01

Tags for this article:

Orphan drugs
Primary myelofibrosis
Ruxolitinib
Ixazomib
Pembrolizumab
Cereblon E3 ligase modulator
Multiple myeloma
Triple-negative breast cancer
Janus kinase inhibitor
Temozolomide
Lenalidomide
Olaparib

Click the tags to see associated articles and topics

View Article Details
Book a Demo